Related Experiment Video
Updated: Jun 5, 2026
11:15
A Preclinical Mouse Model of Osteosarcoma to Define the Extracellular Vesicle-mediated Communication Between Tumor and Mesenchymal Stem Cells
Published on: May 6, 2018
[Right ventricular metastasis of leiomyosarcoma]
Jarosław Rydzek1, Zbigniew Gąsior
1Wojewódzki Szpital Specjalistyczny, Częstochowa. rydzekj@tlen.pl
Kardiologia Polska
|December 22, 2010
Summary
This case study details a 57-year-old patient with right ventricular leiomyosarcoma metastasis. Despite prior treatment, advanced disease and comorbidities complicated management, leading to palliative chemotherapy with a poor long-term prognosis.
Area of Science:
- Cardiology
- Oncology
- Pathology
Background:
- A 57-year-old patient with a history of leiomyosarcoma excision and radiotherapy presented with a right ventricular metastasis.
- The patient had a significant medical history including three remote myocardial infarctions, complicating the diagnostic process.
Observation:
- Non-characteristic symptoms and a history of coronary heart disease delayed the diagnosis and treatment of the metastasis.
- The leiomyosarcoma metastasis was advanced, precluding surgical intervention.
Findings:
- The patient's good clinical condition permitted palliative treatment with gemcitabine chemotherapy.
- Despite palliative treatment, the long-term prognosis for this advanced right ventricular metastasis remains poor.
Implications:
- This case highlights the challenges in diagnosing and managing late-stage metastatic leiomyosarcoma, particularly in patients with cardiovascular comorbidities.
- It underscores the importance of considering rare metastatic presentations in patients with a history of sarcoma.
- Palliative chemotherapy may offer a treatment option for selected patients with advanced disease, even with a guarded prognosis.
